Antioxidant supplementation for the prevention of kwashiorkor in Malawian children: randomised, double blind, placebo controlled trial. Issue 7500 (25th April 2005)
- Record Type:
- Journal Article
- Title:
- Antioxidant supplementation for the prevention of kwashiorkor in Malawian children: randomised, double blind, placebo controlled trial. Issue 7500 (25th April 2005)
- Main Title:
- Antioxidant supplementation for the prevention of kwashiorkor in Malawian children: randomised, double blind, placebo controlled trial
- Authors:
- Ciliberto, Heather
Ciliberto, Michael
Briend, Andreé
Ashorn, Per
Bier, Dennis
Manary, Mark - Abstract:
- Abstract: Objective To evaluate the efficacy of antioxidant supplementation in preventing kwashiorkor in a population of Malawian children at high risk of developing kwashiorkor. Design Prospective, double blind, placebo controlled trial randomised by household. Setting 8 villages in rural southern Malawi. Participants 2372 children in 2156 households aged 1-4 years were enrolled; 2332 completed the trial. Intervention Daily supplementation with an antioxidant powder containing riboflavin, vitamin E, selenium, and N-acetylcysteine in a dose that provided about three times the recommended dietary allowance of each nutrient or placebo for 20 weeks. Main outcome measures The primary outcome was the incidence of oedema. Secondary outcomes were the rates of change for weight and length and the number of days of infectious symptoms. Results 62 children developed kwashiorkor (defined by the presence of oedema); 39/1184 (3.3%) were in the antioxidant group and 23/1188 (1.9%) were in the placebo group (relative risk 1.70, 95% confidence interval 0.98 to 2.42). The two groups did not differ in rates of weight or height gain. Children who received antioxidant supplementation did not experience less fever, cough, or diarrhoea. Conclusions Antioxidant supplementation at the dose provided did not prevent the onset of kwashiorkor. This finding does not support the hypothesis that depletion of vitamin E, selenium, cysteine, or riboflavin has a role in the development of kwashiorkor.
- Is Part Of:
- BMJ. Volume 330:Issue 7500(2005)
- Journal:
- BMJ
- Issue:
- Volume 330:Issue 7500(2005)
- Issue Display:
- Volume 330, Issue 7500 (2005)
- Year:
- 2005
- Volume:
- 330
- Issue:
- 7500
- Issue Sort Value:
- 2005-0330-7500-0000
- Page Start:
- 1109
- Page End:
- Publication Date:
- 2005-04-25
- Subjects:
- Medicine -- Periodicals
Medicine -- Periodicals
Medicine
Periodicals
610 - Journal URLs:
- http://www.bmj.com/archive ↗
http://www.jstor.org/journals/09598138.html ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/3/ ↗
http://www.bmj.com/bmj/ ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/bmj.38427.404259.8F ↗
- Languages:
- English
- ISSNs:
- 0007-1447
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25921.xml